Differential gene expression analysis of the six genes revealed significant upregulation of SPP1, VEGFA, POSTN, and RUNX2 (p < 0.001), whereas CD44 and FOXO1 were significantly down-regulated in primary lung cancer patient samples compared to healthy control samples (p < 0.001) (Fig. 2B). This evidence concerns the gene RUNX2 and lung carcinoma.